FIELD: chemistry.
SUBSTANCE: invention relates to substituted pyrrole compounds of formula (Ia), (Ib) or (Id) which modulate the activity of protein kinases and therefore are useful in treating diseases caused by dysregulated protein kinase activity, in particular JAK family kinases.
R4 :
.
EFFECT: invention also relates to methods for preparing these compounds, pharmaceutical compositions comprising these compounds, and the use of these compounds for cancer treatment.
8 cl, 3 tbl, 15 ex
Title | Year | Author | Number |
---|---|---|---|
SUBSTITUTED PYRIMIDINYL PYRROLES ACTIVE AS KINASE INHIBITORS | 2012 |
|
RU2621732C2 |
ARYLAMIDE DERIVATIVES AS TTX-S BLOCKERS | 2011 |
|
RU2535671C1 |
USING EP4 RECEPTOR LIGANDS IN TREATMENT OF IL-6-MEDIATED DISEASES | 2003 |
|
RU2285527C2 |
NEW COMPOUNDS AND COMPOSITIONS FOR NAMPT INHIBITION | 2011 |
|
RU2617988C2 |
PYRROLE DERIVATIVES AS MEDICINAL SUBSTANCES | 2005 |
|
RU2470916C2 |
TRICYCLIC HETEROCYCLIC COMPOUNDS AND JAK INHIBITORS | 2012 |
|
RU2632870C2 |
SPIROCYCLIC PYRROLOPYRAZINE(PIPERIDINE)AMIDES AS IONIC CHANNELS MODULATORS | 2012 |
|
RU2634900C2 |
SUBSTITUTED HETEROCYCLIC SULPHONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS | 2014 |
|
RU2675792C2 |
PRIMARY CARBOXAMIDES AS BTK INHIBITORS | 2014 |
|
RU2708395C2 |
PYRROLOPYRIDINONE DERIVATIVES AS TTX-S BLOCKERS | 2013 |
|
RU2646754C2 |
Authors
Dates
2018-09-11—Published
2013-07-24—Filed